Clinical and Psychological Factors to Consider in Achieving Treatment-Free Remission in Patients With Chronic Myeloid Leukemia
Treatment of chronic myeloid leukemia (CML) has evolved dramatically in recent years. In this regard, the introduction of second-generation tyrosine kinase inhibitors (TKI) has revolutionized therapeutic goals, and it is now desirable to obtain treatment-free remission (TFR), i.e. when a patient who...
Main Authors: | Massimo Breccia, Elisabetta Abruzzese, Mario Annunziata, Luigia Luciano, Simona Sica |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-03-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.631570/full |
Similar Items
-
Treatment free remission in chronic myeloid leukemia: Lights and shadows
by: Matteo Molica, et al.
Published: (2020-09-01) -
Current Strategies and Future Directions to Achieve Deep Molecular Response and Treatment-Free Remission in Chronic Myeloid Leukemia
by: Mario Annunziata, et al.
Published: (2020-06-01) -
Chronic myeloid leukemia patients and treatment-free remission attitudes: a multicenter survey
by: Lou J, et al.
Published: (2018-06-01) -
Treatment-free remission in patients with chronic myeloid leukemia: literature review
by: A. N. Petrova, et al.
Published: (2019-10-01) -
Combination Therapies in Chronic Myeloid Leukemia for Potential Treatment-Free Remission: Focus on Leukemia Stem Cells and Immune Modulation
by: Hui Mu, et al.
Published: (2021-05-01)